ArticleMethods in enzymology2025
Parameterizing non-canonical amino acids for cyclic peptide simulations.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adsorption of Zwitterionic and Capped Amino Acids to Graphene: A Molecular Dynamics Study.ACS omega · 2026Article
- Ensemble Sensitivity to Chemical Modifications in Free and Bound Macrocyclic Peptides.The journal of physical chemistry. B · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Non-canonical amino acids (ncAAs) are increasingly used to expand the functional chemical space available to biomolecular design. They are particularly useful for cyclic peptides, which have smaller interaction surfaces than proteins and thus require precisely tuned high-affinity contacts with very specific chemical motifs to achieve target affinity and selectivity. Despite rapid advances in machine learning for biomolecular modeling and design, physics-driven approaches remain the predominant choice for exotic chemistries because they pair generalizable, classically defined energy functions/force fields with scalable performance. High-quality, transferable parameters exist for the 20 canonical amino acids, but not for the far larger space of ncAAs; as a result, practitioners are often required to create their own residue definitions before meaningful scoring, sampling, or molecular dynamics (MD) simulations are possible. Doing so is challenging because it is a multi-step process requires careful attention to ensure compatibility of the residue definition for the target modeling tools (e.g., Rosetta and AMBER). Here we provide a guide for building custom ncAAs for biomolecular modeling and design in Rosetta and MD simulation in AMBER. Our guide is presented specifically in the context of cyclic peptide modeling. We provide sample scripts for each major step of the protocol and include validation checkpoints and representative outputs. Together, we anticipate that these resources will enable novices and experts alike to efficiently generate robust ncAA parameters for Rosetta-based modeling/design and AMBER MD simulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.